强生Johnson & Johnson (JNJ) 2014年年度报告「NYSE」.pdf

1、2014A N N U A L R E P O R T I am often asked what led me to work in health care and why I chose to spend most of my career at Johnson&Johnson.From my first job at Janssen,the flagship company of our Pharmaceutical segment,to my current role as the companys Chairman and CEO 25 years later,the answer

2、always begins with Our Credo.A simple yet powerful document penned by General Robert Wood Johnson,the son of our founder and our companys first Chairman,Our Credo outlines the Companys commitments and responsibilities to the people and communities we touch every day with our products and services.Fo

3、r more than 70 years now,it has served as the moral compass of Johnson&Johnson ensuring we never lose sight of our strong values and the important needs of the many stakeholders we serve.Thats why I consider Our Credo to be one of the most visionary statements of corporate purpose ever written.Perha

4、ps theres no better proof of that than the success Johnson&Johnson achieved in 2014.We delivered solid financial results,with full-year 2014 sales of$74.3 billion and adjusted net earnings of$17.1 billion,while also continuing to make investments to accelerate growth for the long term.And while I am

5、 pleased with our performance,we know that we can never rest,because providing sustainable high-quality health care is one of our societys greatest challenges.This is an unprecedented era in human history.The historic aging rate of the worlds population,along with a growing middle class around the w

6、orld,brings dramatically greater demand for higher quality health care;and governments and health systems must manage this with increasingly strained resources.At Johnson&Johnson,Our Credo compels us to innovate in areas where there are unmet medical needs,overcome barriers and advance THERE IS NO C